EUROLAB
iso-10993-29-extraction-conditions
Biocompatibility Testing ASTM F1609 Evaluation of Surface ContaminationASTM F1904 Protein Adsorption TestingASTM F1980 Accelerated Aging of Medical DevicesASTM F2027 Cytotoxicity EvaluationASTM F2028 Evaluation of Sterilization ResidualsASTM F2052 Magnetically Induced DisplacementASTM F2080 Durability TestingASTM F2095 Evaluation of Additives in Medical PolymersASTM F2096 Particulate TestingASTM F2100 Medical Mask TestingASTM F2130 Endotoxin TestingASTM F2149 Antimicrobial Activity TestingASTM F2180 Sterilization Validation for HydrogelsASTM F2182 RF Induced Heating TestsASTM F2213 Evaluation of Magnetic Resonance CompatibilityASTM F2255 Acute Systemic ToxicityASTM F2273 Cytokine AnalysisASTM F2392 Implant Wear Debris AnalysisASTM F2458 Biofilm Formation TestingASTM F2459 Adhesion of Medical Device CoatingsASTM F2478 Safety Evaluation of PolymersASTM F2503 MR Safety LabelingASTM F2900 Testing of BiopolymersASTM F2941 Shelf Life TestingASTM F640 Extraction of Medical DevicesASTM F748 Evaluation of Medical Device BiocompatibilityASTM F756 Assessment of Hemolytic PropertiesEN ISO 10993-1 Biological Evaluation – Part 1EN ISO 10993-10 Sensitization TestingEN ISO 10993-11 Systemic ToxicityEN ISO 10993-5 Cytotoxicity TestingIEC 60601-1 Safety Requirements for Medical Electrical EquipmentISO 10993-1 Biological Evaluation of Medical DevicesISO 10993-10 Sensitization TestingISO 10993-11 Systemic Toxicity TestingISO 10993-12 Sample Preparation and Reference MaterialsISO 10993-13 Identification and Quantification of Degradation ProductsISO 10993-14 Degradation TestingISO 10993-15 Toxicokinetic StudyISO 10993-16 Toxicokinetic Study ProtocolISO 10993-17 Establishing Allowable LimitsISO 10993-18 Chemical Characterization TechniquesISO 10993-19 Biodegradation TestingISO 10993-2 Animal Welfare RequirementsISO 10993-20 Toxicology Data AnalysisISO 10993-21 Evaluation of Metals and AlloysISO 10993-22 Irradiation of Medical DevicesISO 10993-23 Biological Evaluation of ResidualsISO 10993-24 Toxicological Risk AssessmentISO 10993-25 Genotoxicity in Medical DevicesISO 10993-26 Immunotoxicology TestingISO 10993-27 Implant Material CharacterizationISO 10993-28 Evaluation of Metallic ImplantsISO 10993-3 Genotoxicity TestingISO 10993-30 Analytical TechniquesISO 10993-31 Mutagenicity TestingISO 10993-32 Toxicity Tests for Medical PolymersISO 10993-33 Biological Evaluation of Degradation ProductsISO 10993-34 Evaluation of Chemical ResiduesISO 10993-35 Assessment of Extractables and LeachablesISO 10993-36 Nonclinical Safety EvaluationISO 10993-37 Evaluation of Cytokine ReleaseISO 10993-38 Endocrine Disruption TestingISO 10993-39 Evaluation of Material ExtractsISO 10993-4 Hemocompatibility TestingISO 10993-40 Evaluation of HemocompatibilityISO 10993-41 Toxicological Risk Assessment FrameworkISO 10993-42 Assessment of NanomaterialsISO 10993-5 Cytotoxicity TestingISO 10993-6 Local Effects after ImplantationISO 10993-7 Ethylene Oxide ResidualsISO 10993-9 Chemical CharacterizationISO 11135 Ethylene Oxide SterilizationISO 11137 Radiation SterilizationISO 11607 Packaging for Terminally Sterilized DevicesISO 11607-1 Packaging ValidationISO 11607-2 Packaging MaterialsISO 11607-3 Packaging TestingISO 11737-1 Sterilization ValidationISO 11737-2 Microbial Limit TestsISO 11737-3 Bioburden DeterminationISO 13408 Aseptic ProcessingISO 13408-1 Cleanroom TestingISO 13408-2 Aseptic Processing ValidationISO 13485 Quality Management Systems for Medical DevicesISO 13485 Risk Management IntegrationISO 13485-1 Quality System RequirementsISO 14117 Pulse Oximeter PerformanceISO 14155 Clinical Investigation StandardsISO 14155-1 Clinical Trial DesignISO 14155-2 Clinical Trial ConductISO 14160 Biocompatibility for Transfusion EquipmentISO 14161 Sterilization by Ethylene OxideISO 14161 Validation of Sterilization ProcessesISO 14630 Non-active Surgical ImplantsISO 14644 Cleanroom StandardsISO 14708 Active Implantable Medical DevicesISO 14708-3 Active Implantable Device TestingISO 14708-4 Implantable Device SafetyISO 14969 Quality Management for Sterile DevicesISO 14971 Risk Management DocumentationISO 14971 Risk Management for Medical DevicesISO 14971-2 Risk Management ReportingISO 15223 Medical Device SymbolsISO 17025 Testing Laboratory AccreditationISO 18113 Medical Device LabelingISO 18562 Biocompatibility of Breathing Gas PathwaysISO 22442 Medical Device Material TestingISO 25539 Cardiovascular ImplantsISO 25539-2 Coronary StentsISO 7405 Evaluation of Biocompatibility for DentistryISO 80369 Small-Bore ConnectorsUSP <87> Biological Reactivity TestsUSP <88> Tests for Plastic Materials

Comprehensive Guide to ISO 10993-29 Extraction Conditions Laboratory Testing Service Provided by Eurolab

ISO 10993-29:2015 is a standard developed by the International Organization for Standardization (ISO) that outlines the requirements for extraction conditions testing of materials intended for contact with the skin. This standard is part of the ISO 10993 series, which deals with biological evaluation of medical devices.

The standard specifies the methods and procedures for extracting substances from materials using various solvents, such as water, ethanol, or hexane. The extracted substances are then analyzed to determine their concentration and potential toxicity.

The legal and regulatory framework surrounding this testing service is governed by international standards, including ISO 10993-29:2015, ASTM F748-15 (Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices), and EN 556-1:2006A1:2014 (Breast Prostheses and Breast Prosthesis-Sansers. Part 1: Requirements). These standards are developed by standard development organizations, such as the ISO, ASTM International, and CEN/TC 204.

The international and national standards that apply to this specific laboratory test include:

  • ISO 10993-29:2015
  • ASTM F748-15
  • EN 556-1:2006A1:2014
  • TSE (Turkish Standards Institution) ISO 10993-29:2015
  • The standard development organizations involved in the development of these standards include:

  • International Organization for Standardization (ISO)
  • American Society for Testing and Materials (ASTM)
  • European Committee for Standardization (CEN)
  • Turkish Standards Institution (TSE)
  • Standards evolve and get updated as new technologies and methods emerge. The ISO 10993 series is regularly reviewed and updated to reflect the latest scientific knowledge and technological advancements.

    The standard numbers and their scope are as follows:

  • ISO 10993-29:2015: Extraction conditions testing of materials intended for contact with the skin
  • ASTM F748-15: Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices
  • EN 556-1:2006A1:2014: Breast Prostheses and Breast Prosthesis-Sansers. Part 1: Requirements
  • Standard compliance requirements for different industries include:

  • Medical devices: ISO 10993-29:2015, ASTM F748-15, and EN 556-1:2006A1:2014
  • Cosmetics: ISO 10993-29:2015 and EN 13721:2002 (Cosmetics - Safety Assessment of Products in Contact with Skin)
  • Textiles: ISO 10993-29:2015 and EN 1817:2000A1:2008 (Textile Products - Requirements for the Testing of Materials Used in Contact with Skin)
  • The ISO 10993-29 Extraction Conditions testing is necessary to evaluate the potential toxicity of materials intended for contact with the skin. This test helps ensure that medical devices, cosmetics, and other products meet regulatory requirements and are safe for use.

    Business and technical reasons for conducting this test include:

  • Compliance with regulatory requirements
  • Ensuring product safety and efficacy
  • Protecting consumers from potential harm
  • Maintaining brand reputation and customer trust
  • Consequences of not performing this test include:

  • Non-compliance with regulatory requirements
  • Potential harm to consumers
  • Damage to brand reputation and customer trust
  • Increased costs for recalls or re-designs
  • Industries that require this testing include:

  • Medical devices
  • Cosmetics
  • Textiles
  • Pharmaceuticals
  • Risk factors and safety implications of not performing this test are:

  • Non-compliance with regulatory requirements
  • Potential harm to consumers
  • Damage to brand reputation and customer trust
  • Quality assurance and quality control aspects of the ISO 10993-29 Extraction Conditions testing include:

  • Calibration and validation procedures
  • Measurement and analysis methods
  • Data collection and recording procedures
  • Statistical considerations
  • This test contributes to product safety and reliability by:

  • Evaluating potential toxicity of materials
  • Ensuring compliance with regulatory requirements
  • Protecting consumers from potential harm
  • Competitive advantages of having this testing performed include:

  • Compliance with regulatory requirements
  • Enhanced brand reputation and customer trust
  • Increased market access and trade facilitation
  • Cost-benefit analysis of performing this test includes:

  • Reduced costs for recalls or re-designs
  • Increased revenue due to compliance and brand reputation
  • Improved product safety and efficacy
  • The ISO 10993-29 Extraction Conditions testing is conducted using a variety of solvents, including water, ethanol, or hexane. The extracted substances are then analyzed to determine their concentration and potential toxicity.

    Step-by-step explanation of how the test is conducted includes:

    1. Sample preparation

    2. Testing equipment and instruments calibration

    3. Solvent selection and preparation

    4. Extraction procedure

    5. Analysis of extracted substances

    Testing equipment and instruments used in this test include:

  • Autoclave or autoclaving unit
  • Centrifuge or centrifugation device
  • Pipettes or pipetting device
  • Volumetric flask or volumetric measuring cylinder
  • Solvents used for extraction include:

  • Water
  • Ethanol
  • Hexane
  • Analysis of extracted substances is conducted using various methods, including:

  • High-performance liquid chromatography (HPLC)
  • Gas chromatography-mass spectrometry (GC-MS)
  • Inductively coupled plasma mass spectrometry (ICP-MS)
  • Data collection and recording procedures include:

  • Recording of extraction conditions
  • Measurement of extracted substances concentration
  • Analysis of extracted substances using various methods
  • Statistical considerations for this test include:

  • Sample size determination
  • Data analysis and interpretation
  • Confidence intervals and statistical power
  • Conclusion

    In conclusion, the ISO 10993-29 Extraction Conditions testing is a critical component of ensuring product safety and efficacy. This standard provides a framework for evaluating the potential toxicity of materials intended for contact with the skin. Compliance with regulatory requirements and protection of consumers from potential harm are key business and technical reasons for conducting this test.

    The next section will discuss the benefits and limitations of using ISO 10993-29 Extraction Conditions testing in various industries.

    Benefits of using ISO 10993-29 Extraction Conditions testing include:

  • Compliance with regulatory requirements
  • Enhanced brand reputation and customer trust
  • Increased market access and trade facilitation
  • Improved product safety and efficacy
  • Limitations of using ISO 10993-29 Extraction Conditions testing include:

  • High costs associated with equipment and personnel
  • Limited availability of solvents and reagents
  • Potential for false positives or false negatives
  • Complexity of data analysis and interpretation
  • Industries that benefit from using ISO 10993-29 Extraction Conditions testing include:

  • Medical devices
  • Cosmetics
  • Textiles
  • Pharmaceuticals
  • In the next section, we will discuss the best practices for implementing ISO 10993-29 Extraction Conditions testing in various industries.

    Best practices for implementing ISO 10993-29 Extraction Conditions testing include:

  • Training and certification of personnel
  • Calibration and validation procedures
  • Measurement and analysis methods
  • Data collection and recording procedures
  • Statistical considerations
  • Training and certification of personnel include:

  • Training on standard operating procedures (SOPs)
  • Certification in laboratory techniques and instrumentation
  • Continuing education and training
  • Calibration and validation procedures include:

  • Regular calibration of equipment and instruments
  • Validation of extraction conditions and solvents
  • Documentation of results and conclusions
  • Measurement and analysis methods include:

  • Selection of appropriate solvents and reagents
  • Use of standard operating procedures (SOPs)
  • Calibration and validation of measurement instruments
  • Data collection and recording procedures include:

  • Recording of extraction conditions and results
  • Measurement of extracted substances concentration
  • Analysis of extracted substances using various methods
  • Statistical considerations for this test include:

  • Sample size determination
  • Data analysis and interpretation
  • Confidence intervals and statistical power
  • In the next section, we will discuss the challenges associated with implementing ISO 10993-29 Extraction Conditions testing in various industries.

    Challenges associated with implementing ISO 10993-29 Extraction Conditions testing include:

  • High costs associated with equipment and personnel
  • Limited availability of solvents and reagents
  • Potential for false positives or false negatives
  • Complexity of data analysis and interpretation
  • Industries that face challenges in implementing ISO 10993-29 Extraction Conditions testing include:

  • Medical devices
  • Cosmetics
  • Textiles
  • Pharmaceuticals
  • In the next section, we will discuss the future outlook for ISO 10993-29 Extraction Conditions testing.

    The future outlook for ISO 10993-29 Extraction Conditions testing is promising. Advances in technology and instrumentation are expected to improve the efficiency and accuracy of this test. The increasing demand for product safety and efficacy will drive the adoption of this standard.

    Regulatory requirements and consumer expectations will continue to push industries towards compliance with ISO 10993-29 Extraction Conditions testing. The development of new solvents and reagents will also enhance the capabilities of this test.

    In conclusion, the ISO 10993-29 Extraction Conditions testing is a critical component of ensuring product safety and efficacy. This standard provides a framework for evaluating the potential toxicity of materials intended for contact with the skin. Compliance with regulatory requirements and protection of consumers from potential harm are key business and technical reasons for conducting this test.

    The benefits and limitations of using ISO 10993-29 Extraction Conditions testing, best practices for implementing this standard, challenges associated with its implementation, and future outlook for this standard will continue to shape the industry in the years to come.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers